Northern Trust’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$117M Sell
929,058
-28,222
-3% -$3.55M 0.02% 648
2025
Q1
$106M Sell
957,280
-24,659
-3% -$2.73M 0.02% 684
2024
Q4
$134M Buy
981,939
+210,315
+27% +$28.7M 0.02% 600
2024
Q3
$88.9M Sell
771,624
-38,996
-5% -$4.49M 0.01% 696
2024
Q2
$112M Buy
810,620
+95,552
+13% +$13.2M 0.02% 590
2024
Q1
$98.6M Sell
715,068
-92,213
-11% -$12.7M 0.02% 634
2023
Q4
$106M Sell
807,281
-36,062
-4% -$4.75M 0.02% 605
2023
Q3
$94.9M Sell
843,343
-4,869
-0.6% -$548K 0.02% 611
2023
Q2
$80M Sell
848,212
-27,398
-3% -$2.58M 0.02% 681
2023
Q1
$88.6M Buy
875,610
+14,068
+2% +$1.42M 0.02% 645
2022
Q4
$103M Buy
861,542
+3,387
+0.4% +$405K 0.02% 565
2022
Q3
$91.1M Sell
858,155
-12,167
-1% -$1.29M 0.02% 578
2022
Q2
$84.8M Sell
870,322
-12,769
-1% -$1.24M 0.02% 615
2022
Q1
$82.8M Buy
883,091
+8,680
+1% +$814K 0.01% 715
2021
Q4
$74.5M Sell
874,411
-39,388
-4% -$3.35M 0.01% 824
2021
Q3
$87.6M Buy
913,799
+17,940
+2% +$1.72M 0.02% 708
2021
Q2
$87.2M Sell
895,859
-65,144
-7% -$6.34M 0.02% 743
2021
Q1
$93.5M Buy
961,003
+327,101
+52% +$31.8M 0.02% 700
2020
Q4
$60.8M Sell
633,902
-8,233
-1% -$789K 0.01% 926
2020
Q3
$61.7M Sell
642,135
-36,572
-5% -$3.52M 0.01% 779
2020
Q2
$82.8M Buy
678,707
+82,118
+14% +$10M 0.02% 603
2020
Q1
$51.6M Buy
596,589
+43,924
+8% +$3.8M 0.01% 760
2019
Q4
$59.4M Buy
552,665
+112,033
+25% +$12M 0.01% 897
2019
Q3
$39.7M Sell
440,632
-6,231
-1% -$561K 0.01% 1150
2019
Q2
$37.7M Buy
446,863
+162
+0% +$13.7K 0.01% 1211
2019
Q1
$39.4M Buy
446,701
+5,972
+1% +$526K 0.01% 1160
2018
Q4
$31.5M Buy
440,729
+1,100
+0.3% +$78.6K 0.01% 1218
2018
Q3
$54.1M Sell
439,629
-8,507
-2% -$1.05M 0.01% 952
2018
Q2
$44M Sell
448,136
-35,665
-7% -$3.5M 0.01% 1117
2018
Q1
$40.1M Buy
483,801
+15,395
+3% +$1.28M 0.01% 1156
2017
Q4
$36.3M Buy
468,406
+7,475
+2% +$580K 0.01% 1260
2017
Q3
$28.2M Sell
460,931
-15,032
-3% -$921K 0.01% 1449
2017
Q2
$21.9M Buy
475,963
+3,887
+0.8% +$179K 0.01% 1607
2017
Q1
$20.4M Buy
472,076
+14,493
+3% +$628K 0.01% 1622
2016
Q4
$17.7M Sell
457,583
-44,626
-9% -$1.73M 0.01% 1687
2016
Q3
$25.4M Buy
502,209
+46,843
+10% +$2.37M 0.01% 1386
2016
Q2
$20.7M Sell
455,366
-597,167
-57% -$27.1M 0.01% 1505
2016
Q1
$41.6M Buy
1,052,533
+15,057
+1% +$596K 0.01% 927
2015
Q4
$58.7M Buy
1,037,476
+12,258
+1% +$693K 0.02% 694
2015
Q3
$40.8M Buy
1,025,218
+15,372
+2% +$612K 0.01% 942
2015
Q2
$48.2M Buy
1,009,846
+18,882
+2% +$902K 0.01% 884
2015
Q1
$39.4M Buy
990,964
+95,075
+11% +$3.78M 0.01% 1047
2014
Q4
$20M Sell
895,889
-35,036
-4% -$783K 0.01% 1542
2014
Q3
$14.6M Buy
930,925
+16,626
+2% +$261K ﹤0.01% 1756
2014
Q2
$13.6M Sell
914,299
-81,883
-8% -$1.21M ﹤0.01% 1817
2014
Q1
$16M Buy
996,182
+26,430
+3% +$426K 0.01% 1758
2013
Q4
$9.06M Sell
969,752
-23,378
-2% -$218K ﹤0.01% 2151
2013
Q3
$11.2M Sell
993,130
-20,785
-2% -$235K ﹤0.01% 1942
2013
Q2
$13.6M Buy
+1,013,915
New +$13.6M ﹤0.01% 1688